U.S., April 7 -- ClinicalTrials.gov registry received information related to the study (NCT07510945) titled 'HSK3486 (Cipepofol) Injectable Emulsion for Induction of General Anesthesia in Pediatric Subjects Undergoing Elective Surgery' on March 29.
Brief Summary: This multicenter, randomized, double-blinded, propofol-controlled Phase 3b study enrolls pediatric subjects aged 3-17 years undergoing elective surgery with endotracheal intubation. Its primary purpose is to evaluate whether cipepofol is non-inferior to propofol in success of induction of general anesthesia in pediatrics undergoing elective surgery.
Study Start Date: May, 2026
Study Type: INTERVENTIONAL
Condition:
General Anesthetic
Intervention:
DRUG: HSK3486
HSK3486 for i...